R. Solà

448 total citations
15 papers, 288 citations indexed

About

R. Solà is a scholar working on Hepatology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, R. Solà has authored 15 papers receiving a total of 288 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hepatology, 7 papers in Epidemiology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in R. Solà's work include Hepatitis C virus research (7 papers), Liver Disease Diagnosis and Treatment (5 papers) and Liver Disease and Transplantation (3 papers). R. Solà is often cited by papers focused on Hepatitis C virus research (7 papers), Liver Disease Diagnosis and Treatment (5 papers) and Liver Disease and Transplantation (3 papers). R. Solà collaborates with scholars based in Spain, United Kingdom and United States. R. Solà's co-authors include S. Coll, Germán Soriano, Jordi Gana, María Novella, Maria Carme Vila, F Vilardell, Jordí Ortiz, M. Andreu, M Sàbat and Carlos Guarner and has published in prestigious journals such as Hepatology, Journal of Hepatology and Clinical Pharmacology & Therapeutics.

In The Last Decade

R. Solà

15 papers receiving 276 citations

Peers

Countries citing papers authored by R. Solà

Since Specialization

Citations

This map shows the geographic impact of R. Solà's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Solà with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Solà more than expected).

Fields of papers citing papers by R. Solà

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Solà. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Solà. The network helps show where R. Solà may publish in the future.

Co-authorship network of co-authors of R. Solà

This figure shows the co-authorship network connecting the top 25 collaborators of R. Solà. A scholar is included among the top collaborators of R. Solà based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Solà. R. Solà is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Applicability and accuracy improvement of transient elastography using the M and XL probes by experienced operators 2014 ·Journal of Viral Hepatitis ·J.A. Carrión, Marc Puigvehí, S. Coll, Montserrat Garcı́a-Retortillo, Núria Cañete, (unknown), C. Márquez, (unknown), M. García García, Felipe Bory, R. Solà	23
2	439 I148M PNPLA3 VARIANT PROMOTES STEATOSIS ACCORDING TO VIRAL AND IL28B GENOTYPE BUT DOES NOT AFFECT SUSTAINED VIRAL RESPONSE IN PATIENTS WITH HEPATITIS C 2013 ·Journal of Hepatology ·Javier Ampuero, (unknown), (unknown), Lourdes Ortiz‐Fernández, (unknown), R. Solà, Xavier Forns, Raúl J. Andrade, M. Diago, J.A. Pons, José María Navarro, Raquel Millán, María Francisca González‐Escribano, (unknown)	2
3	1154 PEGINTERFERON ALPHA-2A ACHIEVES HIGHER EARLY VIROLOGICAL RESPONSES (RVR AND CEVR) THAN PEGINTERFERON ALPHA-2B IN CHRONIC HEPATITIS C: META-ANALYSIS OF RANDOMIZED CLINICAL TRIALS (RCT) 2012 ·Journal of Hepatology ·Manuel Romero‐Gómez, Ramón Planas, R. Solà, Javier García‐Samaniego, M. Diago, Javier Crespo, José Luís Calleja, Juan Turnés	2
4	Natural prevalence of HCV minority variants that are highly resistant to NS3/4A protease inhibitors 2011 ·Journal of Viral Hepatitis ·Sandra Franco, (unknown), (unknown), Núria Cañete, Montserrat Garcı́a-Retortillo, R. Solà, Cristina Tural, Bonaventura Clotet, Roger Paredes, Miguel Ángel Martı́nez	12
5	A clinical staging system for cirrhosis: a multicenter cohort study of 1858 patients 2011 ·Zeitschrift für Gastroenterologie ·Michael Döllinger, Gennaro D’Amico, (unknown), AK Burroughs, Ramón Planas, R. Solà, Paul Calès, Michele D’Amico, (unknown), Matteo Garcovich, Alexander Zipprich, R Morillas, Isabel Cirera, Guillaume Roquin, (unknown), Alan Colomo, Núria Cañete, (unknown), Jérôme Boursier, Linda Pasta	5
6	[648] CHARACTERISATION OF HCV GENOTYPE 2/3 PATIENTS WITHOUT A RAPID VIROLOGICAL RESPONSE (RVR): OPTIMISING TREATMENT BY PREDICTING SLOWER RESPONDERS TO PEGINTERFERON a-2a (PEGASYS®) PLUS RIBAVIRIN (COPEGUS®) 2007 ·Journal of Hepatology ·(unknown), E. Minóla, Karl Barange, Stephen Shafran, B. Bacon, R. Solà, Daniel Nelson, (unknown), Amy Lin, Stefan Zeuzem	1
7	[82] RANDOMIZED, COMPARATIVE STUDY OF TERLIPRESSIN AND ALBUMIN VS ALBUMIN ALONE IN PATIENTS WITH CIRRHOSIS AND HEPATORENAL SYNDROME 2007 ·Journal of Hepatology ·Marta Martín–Llahí, (unknown), Milton E Guevara-Valdivia, (unknown), Alberto Monescillo, Germán Soriano, (unknown), (unknown), (unknown), R. Solà, Emilio Fábrega, (unknown), J Rodés, Vicente Arroyo, Pere Ginès	24
8	Histological response to pegIFNα-2a (40KD) plus ribavirin in HIV–hepatitis C virus co-infection 2006 ·AIDS ·Eduardo Lissen, Nathan Clumeck, R. Solà, Maria Cássia Mendes-Corrêa, Joan Montaner, Mark Nelson, Jean DePamphilis, Mário Guimarães Pessôa, Peter Buggisch, Janice Main, Douglas T. Dieterich	38
9	567 Peginterferon alpha-2a (40KD) (PEGASYS®) plus ribavirin (COPEGUS®) for treating chronic hepatitis C genotype 1 in daily clinical practice: Final results of the heracles project 2006 ·Journal of Hepatology ·M. Diago, R. Solà, Antonio Olveira, Manuel Romero‐Gómez, Ramón Planas, Rosalba Moreno, Raymond P. Perez, Javier Salmerón, José M. Enríquez–Navascués, (unknown)	2
10	572 Predictive value and predictive factors of the rapid virological response in chronic hepatitis C treatment 2006 ·Journal of Hepatology ·(unknown), (unknown), (unknown), Isabel Cirera, S. Coll, R. Solà	2
11	Evaluation of renal graft haemodynamia by 51Cr-EDTA and o-[131I]iodohippurate: its use in the early diagnosis of glomerular hyperfiltration 2003 ·Nuclear Medicine Communications ·Montserrat Estorch, (unknown), (unknown), (unknown), C Marí, Albert Flotats, Valle Camacho, R. Solà, M. Barbanoj, Ignasi Carrió	4
12	583 Long-term follow-up of chronic hepatitis C patients non-responders to antiviral treatment 2003 ·Hepatology ·(unknown), Isabel Cirera, S Coll, (unknown), María S. Giménez, Felipe Bory, R. Solà	2
13	Pharmacokinetics of the somatostatin analog lanreotide in patients with severe chronic renal insufficiency 1999 ·Clinical Pharmacology & Therapeutics ·(unknown), (unknown), Adelaida Morte, Josep M. Grinyó, R. Solà, Jaime Vallés Giménez, C. Peraire, J. Cordero, (unknown), F Jané	22
14	Continuous Versus Inpatient Prophylaxis of the First Episode of Spontaneous Bacterial Peritonitis With Norfloxacin 1997 ·Hepatology ·María Novella, R. Solà, Germán Soriano, M. Andreu, Jordi Gana, Jordí Ortiz, S. Coll, M Sàbat, Maria Carme Vila, Carlos Guarner, F Vilardell	144
15	Spontaneous bacterial peritonitis in cirrhotic patients treated using paracentesis or diuretics: Results of a randomized study1 1995 ·Hepatology* ·R. Solà	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact